A detailed history of Orbimed Advisors LLC transactions in Third Harmonic Bio, Inc. stock. As of the latest transaction made, Orbimed Advisors LLC holds 5,779,071 shares of THRD stock, worth $76.7 Million. This represents 1.81% of its overall portfolio holdings.

Number of Shares
5,779,071
Previous 5,779,071 -0.0%
Holding current value
$76.7 Million
Previous $54.6 Million 37.71%
% of portfolio
1.81%
Previous 1.23%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$16.75 - $19.93 $96.8 Million - $115 Million
5,779,071 New
5,779,071 $110 Million

Others Institutions Holding THRD

About Third Harmonic Bio, Inc.


  • Ticker THRD
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,328,900
  • Market Cap $535M
More about THRD
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.